Medications for Opioid Use Disorder (MOUD)
Yes we have effective medications: Read about buprenorphine, methadone and naltrexone.
Our Vision
To substantially and equitably mitigate harms from substance use regionally and nationally.
Clinical
-
-
Substance Use Navigator TeamOur substance use navigators are the special people that make this all work.
-
Success StoriesAddiction is a family disease. While the Smith family came to Philadelphia to be at their father’s bedside during his final days, securing their brother’s medication for opioid use disorder became a barrier. Our CRS team mended this gap of need; offering much needed peace to a family’s already trying time.
Featured Event
Addiction in Philadelphia and Impact of the Kensington Caucus: A Panelist Event and Open Discussion
The Addiction Medicine Interest Group is sponsoring "Addiction in Philadelphia and Impact of the Kensington Caucus: A Panelist Event and Open Discussion" on October 21st at 5:45pm in JMEC 506EW. Catering from Pattaya will be provided.
Education
What is an “X Waiver” and who needs one?
This legal waiver is no longer required for a clinician to prescribe the lifesaving medication buprenorphine. A major shift in policy allows any DEA registered provider to prescribe the drug going forward.
Receive CPE Credit for Attending our Virtual Webinar
Low-barrier care is essential to support our patients. CPE credit available for pharmacists/pharmacy students
News
‘This isn’t about policy’: Vigil honors overdose victims in McPherson Square Park despite disruption from Philly police
‘I didn’t have it in my bag before’: Incoming Penn students say carrying Narcan is shaping their outlook on medicine
FDA Approves First Over-the-Counter Naloxone Nasal Spray
Implementation of an ED Buprenorphine Program
In 3 urban academic emergency departments (EDs), a onetime incentive for X-waiver training was offered.
Success Rates
83
(56,63)
Overall, 89% of eligible emergency physicians completed the X-waiver training during the 6-week incentive period.
Buprenorphine prescribing rates increased to 15% (from <1%) during the first 4 months of the program.
This study shows how enthusiastically emergency physicians embraced the opportunity to obtain this certification, which speaks to the shifting national conversation surrounding opioid use disorder," said Sean Foster, MD. "This also gives a 'playbook' to any leaders and administrators who may be looking for ways to get their group trained."
After the incentive, buprenorphine prescribing per OUD encounter increased from 0.5% to 16%.
Data comes from Providing Incentive for Emergency Physician X-Waiver Training: An Evaluation of Program Success and Postintervention Buprenorphine Prescribing
https://www.annemergmed.com/article/S0196-0644(20)30140-2/pdf
